Related Experiment Video
Updated: Mar 26, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study
Richard L Amdur1,2, Monica Mukherjee3, Alan Go4
1Biostatistics core, George Washington University Medical Faculty Associates, Washington, DC, United States of America.
Insights
Interleukin-6 (IL-6) inflammation is linked to atrial fibrillation (AF) in chronic kidney disease (CKD) patients. This study found elevated IL-6 levels independently predict AF presence and new onset in CKD individuals.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Background:
- Atrial fibrillation (AF) is a common arrhythmia in chronic kidney disease (CKD) patients.
- Inflammation is increasingly recognized as a contributing factor in cardiovascular diseases, including AF.
Purpose of the Study:
- To investigate the association between inflammatory biomarkers and AF in a large cohort of CKD patients.
- To determine if specific inflammatory markers predict the presence or new onset of AF.
Main Methods:
- Analysis of 3,762 adult CKD patients from the Chronic Renal Insufficiency Cohort (CRIC) study.
- Measurement of plasma inflammatory markers (IL-1, IL-1RA, IL-6, TNF-α, TGF-β, hs-CRP, fibrinogen) at baseline.
- AF assessed by self-report and ECG at baseline, with new-onset AF tracked over a mean 3.7-year follow-up.
Main Results:
- No significant association between inflammatory biomarkers and past history of AF.
- Plasma IL-6 levels were significantly associated with the presence of AF at baseline (OR, 1.61; P = 0.001).
- Elevated IL-6 independently predicted new-onset AF during follow-up (OR, 1.25; P = 0.03).
Conclusions:
- Plasma IL-6 is an independent and consistent predictor of AF in patients with CKD.
- Inflammation, specifically IL-6, plays a significant role in the pathophysiology of AF in the CKD population.
Abstract:
Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with chronic kidney disease (CKD). In this study, we examined the association between inflammation and AF in 3,762 adults with CKD, enrolled in the Chronic Renal Insufficiency Cohort (CRIC) study. AF was determined at baseline by self-report and electrocardiogram (ECG). Plasma concentrations of interleukin(IL)-1, IL-1 Receptor antagonist, IL-6, tumor necrosis factor (TNF)-α, transforming growth factor-β, high sensitivity C-Reactive protein, and fibrinogen, measured at baseline. At baseline, 642 subjects had history of AF, but only 44 had AF in ECG recording. During a mean follow-up of 3.7 years, 108 subjects developed new-onset AF. There was no significant association between inflammatory biomarkers and past history of AF. After adjustment for demographic characteristics, comorbid conditions, laboratory values, echocardiographic variables, and medication use, plasma IL-6 level was significantly associated with presence of AF at baseline (Odds ratio [OR], 1.61; 95% confidence interval [CI], 1.21 to 2.14; P = 0.001) and new-onset AF (OR, 1.25; 95% CI, 1.02 to 1.53; P = 0.03). To summarize, plasma IL-6 level is an independent and consistent predictor of AF in patients with CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease I: Introduction

